Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Nano X Imaging
NNOX
$73.5M
| $3.95M | ﹤0.01% |
86,498
+50,677
| +141% | +$2.07M |
|
3952
CALL
Trupanion
TRUP
$1.33B
| $3.95M | ﹤0.01% |
33,000
+2,300
| +7% | +$217K |
|
3953
PUT
Qualys
QLYS
$6.2B
| $3.95M | ﹤0.01% |
32,400
+15,100
| +87% | +$1.49M |
|
3954
PUT
Bright Horizons
BFAM
$3.68B
| $3.94M | ﹤0.01% |
22,800
+12,900
| +130% | +$2.11M |
|
3955
PubMatic
PUBM
$773M
| $3.94M | ﹤0.01% |
+141,057
| New | +$3.86M |
|
3956
Reliance Steel & Aluminium
RS
$21.5B
| $3.94M | ﹤0.01% |
32,916
-15,237
| -32% | -$1.76M |
|
3957
CALL
BJs Wholesale Club
BJ
$11.8B
| $3.94M | ﹤0.01% |
105,700
-144,600
| -58% | -$5.78M |
|
3958
CALL
Cincinnati Financial
CINF
$26.7B
| $3.94M | ﹤0.01% |
45,100
-40,000
| -47% | -$3.19M |
|
|
QVCGA
3959
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $3.94M | ﹤0.01% |
7,176
+6,954
| +3,132% | +$3.13M |
|
|
DCP
3960
CALL
DELISTED
DCP Midstream, LP
DCP
| $3.93M | ﹤0.01% |
212,200
+75,400
| +55% | +$1.19M |
|
3961
NeoGenomics
NEO
$2.04B
| $3.93M | ﹤0.01% |
72,940
-3,795
| -5% | -$171K |
|
|
ETRN
3962
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $3.93M | ﹤0.01% |
488,452
+226,846
| +87% | +$1.81M |
|
3963
PUT
Dynatrace
DT
$13.6B
| $3.92M | ﹤0.01% |
90,700
+4,300
| +5% | +$171K |
|
|
SGMO
3964
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.92M | ﹤0.01% |
251,500
-117,900
| -32% | -$1.38M |
|
3965
VanEck Biotech ETF
BBH
$428M
| $3.92M | ﹤0.01% |
23,149
+16,114
| +229% | +$2.65M |
|
|
PLLL
3966
CALL
DELISTED
Piedmont Lithium Limited American Depositary Receipts
PLLL
| $3.92M | ﹤0.01% |
+147,800
| New | +$3.92M |
|
3967
PUT
Scotiabank
BNS
$112B
| $3.92M | ﹤0.01% |
72,600
+27,900
| +62% | +$1.32M |
|
3968
iShares Global Consumer Staples ETF
KXI
$1.07B
| $3.92M | ﹤0.01% |
+67,321
| New | +$3.83M |
|
3969
iShares Future Exponential Technologies ETF
XT
$4B
| $3.92M | ﹤0.01% |
68,495
-74,161
| -52% | -$3.91M |
|
3970
PUT
Simpson Manufacturing
SSD
$7.88B
| $3.92M | ﹤0.01% |
+41,900
| New | +$3.89M |
|
|
SUM
3971
CALL
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $3.92M | ﹤0.01% |
198,315
-8,136
| -4% | -$151K |
|
3972
CALL
Entergy
ETR
$50.3B
| $3.91M | ﹤0.01% |
78,400
+4,800
| +7% | +$253K |
|
|
QVCGA
3973
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $3.91M | ﹤0.01% |
+7,136
| New | +$3.21M |
|
3974
CALL
Methanex
MEOH
$4.36B
| $3.91M | ﹤0.01% |
84,900
-13,200
| -13% | -$476K |
|
3975
CALL
Celanese
CE
$4.88B
| $3.91M | ﹤0.01% |
30,100
+7,200
| +31% | +$895K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.